VISION PACIFIC LIFESCIENCES CAPITAL
Vision Pacific LifeSciences Capital is a joint venture co-owned by Catalys Pacific and SoftBank Vision Fund 2.
VISION PACIFIC LIFESCIENCES CAPITAL
Status:
Active
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-03-28 | Aculys Pharma | Vision Pacific LifeSciences Capital investment in Series B - Aculys Pharma | 2.8 B JPY |
More informations about "Vision Pacific LifeSciences Capital"
Vision Pacific LifeSciences Capital - Crunchbase
Mar 28, 2022 · Vision Pacific LifeSciences Capital is a joint venture co-owned by Catalys Pacific and SoftBank Vision Fund 2.See details»
Aculys Pharma Closes US$24 Million Series B Financing
Mar 27, 2022 · Existing investors Vision Pacific LifeSciences Capital I, II (DE) LLC 1, HBM Healthcare Investments, Global Founders Capital, Sumitomo Mitsui Trust Investment, and …See details»
Vision Pacific LifeSciences Capital - Updates, News ... - Crunchbase
Vision Pacific LifeSciences Capital is a joint venture co-owned by Catalys Pacific and SoftBank Vision Fund 2.See details»
Vision Pacific LifeSciences Capital - CB Insights
Mar 27, 2022 · Vision Pacific LifeSciences Capital is a joint venture co-owned by Catalys Pacific and SoftBank Vision Fund 2. Use the CB Insights Platform to explore Vision Pacific …See details»
Entity Details :: OpenCorporates
Free and open company data on Delaware (US) company VISION PACIFIC LIFESCIENCES CAPITAL I (DE) LLC (company number 6319012), New Castle, DESee details»
Vision Pacific LifeSciences Capital - BioCentury Company Profiles
Vision Pacific LifeSciences Capital - BioCentury Company Profiles for the biopharma industrySee details»
Meet the 5 most active PE investors in life sciences
Dec 4, 2023 · PE investments in life sciences peaked in 2021, when investors closed 695 PE transactions totaling $127.5 billion, according to PitchBook data. The space includes biotech and medical device companies as well as …See details»
Vision Lifesciences | Experts in Cross-Border Life …
Unlock global opportunities in life sciences. We provide expert guidance on licensing, partnerships, and M&A across Asia, Europe, and the USA.See details»
Oncology and Biologics: Driving Global Biopharma Deals
Jul 9, 2024 · Explore biopharma deal trends: Oncology and biologics lead global partnerships, with insights on major collaborations, emerging areas, and future outlook.See details»
Vision Pacific LifeSciences Capital - Crunchbase
Mar 28, 2022 · Vision Pacific LifeSciences Capital is a joint venture co-owned by Catalys Pacific and SoftBank Vision Fund 2.See details»
Life Sciences Practice Vision 2028: How China could impact the …
Life Sciences Practice Vision 2028: How China could impact the global biopharma industry Biopharmas originating in China will likely have greater influence on the industry by 2028, but …See details»
Minister Ng announces new venture capital investments for life …
Apr 25, 2023 · As part of a combined $450 million investment into venture capital, and together with investments from the private sector, the renewed VCCI is expected to inject over $1.4 …See details»
Series B - Aculys Pharma - 2022-03-28 - Crunchbase
Mar 28, 2022 · Organization Name . Aculys Pharma ... Number of Partner Investors 2. Investor Name . Partners . Vision Pacific LifeSciences Capital — Sumitomo Mitsui Trust Investment — …See details»
Venture capitalists raise more than $100bn to target life sciences
Sep 20, 2021 · Venture capitalists are raising record amounts of cash to pour into life sciences businesses, to gain exposure to a sector which has been in the spotlight during the …See details»
Canadian life sciences: VC investment report Q1 2022
May 17, 2022 · Venture capital investment in Canadian life science companies reached $342 million across 17 deals in the first quarter of 2022 (Figure 1).See details»
Our leaders - Edwards Lifesciences
Bernard J. Zovighian is CEO and on the Board of Directors of Edwards Lifesciences since May 2023, after serving as the company’s president. As CEO, Zovighian is leading Edwards into a …See details»
Biotech | Life Sciences - McKinsey & Company
We invest our human capital—our capabilities, databases, people, and tools—in promising biotech companies to help them scale and achieve high ambitions, using our proven Leap by …See details»
Accelerated growth in Canada’s life sciences industry
In the last three years, venture capital investment in the Canadian life sciences industry has accelerated by almost 250%.See details»
Aculys Pharma - Funding, Financials, Valuation & Investors
Aculys Pharma is a pharmaceutical company that develops drugs and innovative medical treatments for neurological and psychiatric disorders.See details»
Life Sciences Opportunities and Strategies for Expanding Into APAC
In this Special Report, L.E.K. Consulting’s Life Sciences practice explores APAC market entry opportunities and asks: Which markets should be prioritized? What are the optimal market …See details»